[American Thoracic Society American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA - ()] A64. THERAPEUTICS, DRUG DELIVERY, AND TISSUE ENGINEERING - The BCL-xL/BCL-2 Inhibitor Navitoclax Targets Myofibroblasts and Reduces Idiopathic Pulmonary Fibrosis (IPF) in Pre-Clinical Models

The file will be sent to your email address. It may take up to 1-5 minutes before you receive it.

The file will be sent to you via the Telegram messenger. It may take up to 1-5 minutes before you receive it.

Note: Make sure you have linked your account to Z-Library Telegram bot.

The file will be sent to your Kindle account. It may take up to 1–5 minutes before you receive it.

Please note: you need to verify every book you want to send to your Kindle. Check your mailbox for the verification email from Amazon Kindle.